Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Treated With Alemtuzumab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00562328
What this trial is testing

Rituximab, Alemtuzumab, and GM-CSF As First-Line Therapy in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Mayo Clinic 33
Early research (Phase 1)Study completedNCT00104975
What this trial is testing

Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
Yale University 20
Testing effectiveness (Phase 2)Ended earlyNCT00077961
What this trial is testing

Rituximab Plus CAMPATH in Patients With Relapsed/Refractory Low-Grade or Follicular, CD20-positive, B-cell NHL

Who this might be right for
Non-Hodgkin's Lymphoma
Genzyme, a Sanofi Company 49
Not applicableUnknownNCT05075499
What this trial is testing

Immune Response to COVID-19 Vaccine in Multiple Sclerosis Patients Treated With Teriflunomide and Alemtuzumab

Who this might be right for
Multiple Sclerosis
Sheba Medical Center 70
Testing effectiveness (Phase 2)UnknownNCT00157274
What this trial is testing

Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome

Who this might be right for
Mycosis FungoidesSezary Syndrome
Latin American Cooperative Onco-Haematology Group - Peru 20
Testing effectiveness (Phase 2)Study completedNCT00074282
What this trial is testing

Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL

Who this might be right for
Leukemia
Eastern Cooperative Oncology Group 102
Testing effectiveness (Phase 2)Study completedNCT00061945
What this trial is testing

Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia

Who this might be right for
Acute Undifferentiated LeukemiaB-cell Adult Acute Lymphoblastic LeukemiaB-cell Childhood Acute Lymphoblastic Leukemia+11 more
National Cancer Institute (NCI) 302
Testing effectiveness (Phase 2)Study completedNCT00057967
What this trial is testing

Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome

Who this might be right for
Lymphoma
Northwestern University 37
Testing effectiveness (Phase 2)Study completedNCT01269385
What this trial is testing

Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic LeukemiaStage 0 Chronic Lymphocytic Leukemia+2 more
Mayo Clinic 22
Testing effectiveness (Phase 2)Study completedNCT00458523
What this trial is testing

Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia in Partial Remission or Complete Remission

Who this might be right for
Leukemia
Leeds Cancer Centre at St. James's University Hospital 54
Testing effectiveness (Phase 2)WithdrawnNCT00085449
What this trial is testing

Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)Study completedNCT00634881
What this trial is testing

Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
German CLL Study Group 13
Testing effectiveness (Phase 2)Study completedNCT00086775
What this trial is testing

Fludarabine Combined With Either Alemtuzumab or Rituximab in Treating Patients With Refractory or Relapsed B-Cell Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Bayer